| 23 March, 2015 | ICON and Carnegie Mellon University Collaborate to Evaluate Patient-centric Informed Consent Processes |  | 
  | 09 March, 2015 | ICON Launches Medical Device & Diagnostics Research Group |  | 
  | 02 March, 2015 | ICON Completes Acquisition of MediMedia Pharma Solutions |  | 
  | 25 February, 2015 | ICON Reports Fourth Quarter and Full Year 2014 Results and Issues 2015 Earnings Guidance |  | 
  | 02 February, 2015 | ICON to Acquire MediMedia Pharma Solutions |  | 
  | 06 November, 2014 | ICON Selected by the FDA to Develop New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial Pneumonia Trials |  | 
  | 22 October, 2014 | ICON Reports Third Quarter 2014 and Increases Earnings Guidance |  | 
  | 19 September, 2014 | ICON Plc Announces Completion of $40 Million Share Buyback and a Further Share Buyback Program for up to $100 Million |  | 
  | 01 August, 2014 | ICON: Pfizer and Roche Join ADDPLAN DF Consortium |  | 
  | 30 July, 2014 | ICON Reports Second Quarter 2014 and Increases Earnings Guidance |  | 
  | 30 July, 2014 | ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting |  | 
  | 09 May, 2014 | ICON to Webcast Analyst Day Meeting |  | 
  | 08 May, 2014 | ICON Completes Acquisition of Aptiv Solutions |  | 
  | 30 April, 2014 | ICON Announces Appointment of Dr. Hugh Brady to Board of Directors |  | 
  | 30 April, 2014 | ICON Reports First Quarter 2014 |  | 
  | 31 March, 2014 | ICON to Acquire Aptiv Solutions |  | 
  | 20 February, 2014 | ICON Reports Fourth Quarter 2013 Revenue of $345 million, up 15% year on year and EPS of 53c, up 56% year on year. Full Year 2013 Revenue was $1.34 billion, up 20% year on year, EPS was $1.77 up 77% year on year. Guidance issued for 2014. |  | 
  | 20 February, 2014 | ICON Announces Appointment of Ms. Mary Pendergast to Board of Directors |  | 
  | 09 January, 2014 | ICON Appoints Dr. Steve Cutler as Chief Operating Officer |  | 
  | 24 October, 2013 | ICON Reports Third Quarter 2013 Revenue of $340 Million, up 19% Year on Year, EPS of 45C and Raises FY 2013 Guidance. |  |